ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO871

Comorbidity Trends in US Veterans With Advanced CKD Patients Treated With Conservative Management vs. Dialysis

Session Information

Category: CKD (Non-Dialysis)

  • 2201 CKD (Non-Dialysis): Epidemiology‚ Risk Factors‚ and Prevention

Authors

  • Narasaki, Yoko, University of California Irvine, Irvine, California, United States
  • Rhee, Connie, University of California Irvine, Irvine, California, United States
  • Crowley, Susan T., Yale University, New Haven, Connecticut, United States
  • Kovesdy, Csaba P., The University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Mukamel, Dana B., University of California Irvine, Irvine, California, United States
  • You, Amy Seung, University of California Irvine, Irvine, California, United States
  • Yoon, Ji Hoon, University of California Irvine, Irvine, California, United States
  • Nguyen, Danh V., University of California Irvine, Irvine, California, United States
  • Kalantar-Zadeh, Kamyar, University of California Irvine, Irvine, California, United States
Background

While dialysis has been the dominant treatment paradigm for ESKD, this approach may not offer survival benefit nor improved quality of life in certain subgroups (comorbid, elderly). We examined comorbidity trends in a contemporary cohort of US Veterans with advanced CKD treated with dialysis vs. conservative management (CM).

Methods

In a national cohort of US Veterans, we examined patients with advanced CKD (≥2 eGFRs <25ml/min/1.73m2 separated by ≥90 days from 10/2010-9/2019). Using linked USRDS and Medicare (CMS) data, we compared comorbidity trends among patients categorized according to receipt of CM, defined as those who did not receive dialysis within 2-years of the index eGFR (1st eGFR <25), vs. receipt of dialysis within 2-years of the index eGFR.

Results

Among 106,089 advanced CKD patients who met eligibility, 25% and 75% were treated with dialysis vs. CM, respectively. Compared to the dialysis group, CM patients tended to be younger; were more likely to be White; and less likely to be Black or Hispanic. Median (IQR) Charlson Comorbidity Index (CCI) scores in the dialysis vs. CM groups were 7 (6, 9) and 7 (5, 9), respectively (Fig A). Using CMS Chronic Conditions Data Warehouse algorithms, the most prevalent comorbidities in the dialysis group were diabetes (77%), CHF (65%), PVD (50%), CVD (36%), and history of MI (35%) (Fig B). Among the CM group, the most common comorbidities were diabetes (65%), CHF (58%), COPD (50%), PVD (46%), and CVD (37%).

Conclusion

Among US Veterans with advanced CKD, while there were socio-demographic differences among the dialysis vs. CM groups, comorbidity burden defined by CCI score and types of comorbidities were similar. Further studies are needed to identify the clinical phenotype of patients who will most benefit from dialysis vs. CM.

Funding

  • NIDDK Support